Squamous Cell Non-small Cell Lung Cancer Terminated Phase 1 / 2 Trials for Paclitaxel (DB01229)

Also known as: Squamous Cell Carcinoma, Non-Small-Cell Lung / Lung Non-Small Cell Squamous Carcinoma / Non-Small Cell Squamous Lung Carcinoma / Non-Small Cell Squamous Lung Cancer / Squamous Non-Small Cell Lung Cancer (sqNSCLC) / Squamous NSCLC / Squamous Non-Small Cell Lung Cancer / Squamous cell cancer Non-small cell lung cancer / Squamous non-small cell lung cancer (disorder) / Epidermoid carcinoma lung / Squamous cell carcinoma of lung stage unspecified / Lung squamous cell carcinoma stage unspecified / Squamous cell carcinoma of lung (disorder) / Squamous cell carcinoma of lung

IndicationStatusPhase
DBCOND0059210 (Squamous Cell Non-small Cell Lung Cancer)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02204345A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous HistologyTreatment